Weekly docetaxel in ormone refractory prostate cancer patients

被引：0
|
作者：
Lupo, G. [1 ]
Buemi, B. [1 ]
Marabello, G. [1 ]
Pettineo, G. [1 ]
Gnani, A. [1 ]
Caristi, N. [1 ]
Leone, A. [1 ]
Altavilla, G. [1 ]
机构：
[1] Univ Messina, Med Oncol & Innovat Therapies, I-98100 Messina, Italy
来源：
ANNALS OF ONCOLOGY | 2006年 / 17卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：VII153 / VII153
页数：1
相关论文
共 50 条
  • [1] Weekly docetaxel and estramustine in patients with hormone-refractory prostate cancer
    Copur, MS
    Ledakis, P
    Lynch, J
    Hauke, R
    Tarantolo, S
    Bolton, M
    Norvell, M
    Muhvic, J
    Hake, L
    Wendt, J
    SEMINARS IN ONCOLOGY, 2001, 28 (04) : 16 - 21
  • [2] Weekly docetaxel rechallenge in patients with hormone-resistant prostate cancer refractory to conventionally three weekly docetaxel
    Fuxius, S.
    Mueller, A.
    Kleitz, K.
    Schuetz, M.
    Philipps, Ch
    Buvari, P.
    Karcher, A.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [3] Weekly docetaxel for advanced hormone-refractory prostate cancer
    Pepe, A.
    Usset, A.
    Calabria, C.
    Savio, G.
    Palmisano, V.
    Leonardi, V.
    Laudani, A.
    Arcuri, C.
    Giresi, A.
    Agostara, B.
    ANNALS OF ONCOLOGY, 2006, 17 : VII154 - VII154
  • [4] Combination chemotherapy with weekly docetaxel and estramustine for hormone refractory prostate cancer in Japanese patients
    Takenaka, Atsushi
    Yamada, Yuji
    Kurahashi, Toshifumi
    Soga, Hideo
    Miyake, Hideaki
    Fujisawa, Masato
    INTERNATIONAL JOURNAL OF UROLOGY, 2008, 15 (01) : 106 - 109
  • [5] A weekly schedule of docetaxel for metastatic hormone-refractory prostate cancer
    Ferrero, JM
    Foa, C
    Thezenas, S
    Ronchin, P
    Peyrade, F
    Valenza, B
    Lesbats, G
    Garnier, G
    Boublil, JL
    Tchiknavorian, X
    Chevallier, D
    Amiel, J
    ONCOLOGY, 2004, 66 (04) : 281 - 287
  • [6] Weekly administration of docetaxel in patients with hormone-refractory prostate cancer: a pilot study on Japanese patients
    Kojima, T
    Shimazui, T
    Onozawa, M
    Tsukamoto, S
    Hinotsu, S
    Miyanaga, N
    Hattori, K
    Kawai, K
    Akaza, H
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2004, 34 (03) : 137 - 141
  • [7] Weekly docetaxel for advanced hormone-refractory prostate cancer-hrpc
    Pepe, A.
    Usset, A.
    Calabria, C.
    Savio, G.
    Palmisano, V
    Leonardi, V
    Laudani, A.
    Arcuri, C.
    Agostara, B.
    ANNALS OF ONCOLOGY, 2007, 18 : 187 - 187
  • [8] Weekly docetaxel for advanced hormone-refractory prostate cancer-HRPC
    Pepe, A.
    Usset, A.
    Calabria, C.
    Savio, G.
    Palmisano, V
    Leonardi, V
    Laudani, A.
    Arcuri, C.
    Giresi, A.
    Agostara, B.
    ANNALS OF ONCOLOGY, 2006, 17 : XI82 - XI82
  • [9] Three-weekly docetaxel with prednisone is feasible for Japanese patients with hormone-refractory prostate cancer: A retrospective comparative study with weekly docetaxel alone
    Shimazui, Toru
    Kawai, Koji
    Miyanaga, Naoto
    Kojima, Takahiro
    Sekido, Noritoshi
    Hinotsu, Shiro
    Oikawa, Takehiro
    Joraku, Akira
    Akaza, Hideyuki
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2007, 37 (08) : 603 - 608
  • [10] Weekly docetaxel and epirubicin in treatment of advanced hormone-refractory prostate cancer
    Petrioli, Roberto
    Paolelli, Loretta
    Francini, Edoardo
    Manganelli, Antonio
    Salvestrini, Francesco
    Francini, Guido
    UROLOGY, 2007, 69 (01) : 142 - 146
12345